Park WS, Kang SK, Jun MA, Shin MS, Kim KY, Rhee SD, Bae MA, Kim MS, Kim KR, Kang NS, Yoo SE, Lee JO, Song DH, Silinski P, Schneider SE, Ahn JH, Kim SS (2011) <br />Discovery of beta-aminoacyl containing thiazolidine derivatives as potent and selective dipeptidyl peptidase IV inhibitors<br /><i>Bioorganic & Medicinal Chemistry Lett</i> <b>21</b>: 1366<br /><br />Ahn JH, Park WS, Jun MA, Shin MS, Kang SK, Kim KY, Rhee SD, Bae MA, Kim KR, Kim SG, Kim SY, Sohn SK, Kang NS, Lee JO, Lee DH, Cheon HG, Kim SS (2008) <br />Synthesis and biological evaluation of homopiperazine derivatives with beta-aminoacyl group as dipeptidyl peptidase IV inhibitors<br /><i>Bioorganic & Medicinal Chemistry Lett</i> <b>18</b>: 6525<br /><br />Jun MA, Park WS, Kang SK, Kim KY, Kim KR, Rhee SD, Bae MA, Kang NS, Sohn SK, Kim SG, Lee JO, Lee DH, Cheon HG, Kim SS, Ahn JH (2008) <br />Synthesis and biological evaluation of pyrazoline analogues with beta-amino acyl group as dipeptidyl peptidase IV inhibitors<br /><i>Eur Journal of Medicinal Chemistry</i> <b>43</b>: 1889<br /><br />Ahn JH, Shin MS, Jun MA, Jung SH, Kang SK, Kim KR, Rhee SD, Kang NS, Kim SY, Sohn SK, Kim SG, Jin MS, Lee JO, Cheon HG, Kim SS (2007) <br />Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors<br /><i>Bioorganic & Medicinal Chemistry Lett</i> <b>17</b>: 2622<br /><br />Ahn JH, Jung SH, Kim JA, Song SB, Kwon SJ, Kim KR, Rhee SD, Park SD, Lee JM, Kim SS, Cheon HG (2005) <br />Pyrazolidine derivatives with heteroaryl urea as dipeptidyl peptidase IV inhibitors<br /><i>Chem Pharm Bull (Tokyo)</i> <b>53</b>: 1048<br /><br />Cheon HG, Kim SS, Kim KR, Rhee SD, Yang SD, Ahn JH, Park SD, Lee JM, Jung WH, Lee HS, Kim HY (2005) <br />Inhibition of dipeptidyl peptidase IV by novel inhibitors with pyrazolidine scaffold<br /><i>Biochemical Pharmacology</i> <b>70</b>: 22<br /><br />Kim KR, Rhee SD, Kim HY, Jung WH, Yang SD, Kim SS, Ahn JH, Cheon HG (2005) <br />KR-62436, 6-{2-[2-(5-cyano-4,5-dihydropyrazol-1-yl)-2-oxoethylamino]ethylamino}nicotinonitr ile, is a novel dipeptidyl peptidase-IV (DPP-IV) inhibitor with anti-hyperglycemic activity<br /><i>European Journal of Pharmacology</i> <b>518</b>: 63<br /><br />